Alliance for the Prudent Use of Antibiotics
The mission of the Alliance for the Prudent Use of Antibiotics (APUA) is to strengthen global defenses against infectious disease by ensuring access to effective treatment and promoting appropriate antibiotic use to contain drug resistance. With a network of affiliated chapters in 16 countries, APUA stands as the world’s leading organization conducting research and education on antimicrobial treatment and resistance at the grassroots and global levels.
APUA WELCOMES NEW BOARD MEMBERS
APUA is proud to announce the addition of five new members to our Board of Directors:
- Robert Gaynes, MD, Professor - Department of Medicine - Emory School of Medicine
- Shahin Gharakhanian, MD - Cambridge Innovation Center
- Cristina Larkin, Chief Commercial Officer - Spero Therapeutics
- Margaret Riley, PhD, Professor - Department of Biology - University of Massachusetts, Amherst
- David White, PhD, Associate Dean of Research - University of Tennessee School of Agriculture
You can view the complete list of APUA Board members
APUA extends its deepest thanks to Dennis Signorovitch as he completes 10 years of outstanding service as a member of APUA's Board of Directors. His leadership, advice and enthusiasm have aided the organization immeasurably in forwarding its mission and we wish him well in all his future endeavors. Thank you, Dennis!
- Faces of Antimicrobial Resistance (FOAR) releases final report
- Letter to President Trump urges farsightedness
- Letter to WHO calls for continued global action
- Center for Global Development (CGD) proposes global treaty to reduce antibiotic use in livestock
- Hospitals penalized for preventable injuries
- The EU reports escalating resistance trends
- WHO releases first list of global superbugs
- Multidrug resistance rising rapidly among youth
- Scientists reveal two-step process to antibiotic resistance
- PPMO molecule may revitalize older, “useless” antibiotics
- New bacterial amyloid could foster novel antibiotics
- Common Floridian weed can disrupt bacterial signaling
- Soil bacteria compound may help TB therapy
- Three-drug combo shows promise against metallo-beta-lactamases
- “C-dots” poised to treat MRSA
- On-line risk assessment tool could reduce antibiotic use in newborns
- Smartphone device could expand susceptibility testing
- Horizon Prize awards £1million for game-changing diagnostic
- The Longitude Prize releases Discovery Awards
- Publications and Webinars of Note
Antibiotics are humanity's key defense against disease-causing microbes. The growing prevalence of antibiotic resistance threatens a future where these drugs can no longer cure infections and killer epidemics run rampant. The Alliance for the Prudent Use of Antibiotics (APUA) has been the leading global non-governmental organization fighting to preserve the effectiveness of antimicrobial drugs since 1981. With affiliated chapters in over 66 developed and developing countries, we conduct research, education and advocacy programs to control antimicrobial resistance and ensure access to effective antibiotics for current and future generations. For more information on antibiotic resistance research, visit our partner lab at the Center for Adaptation Genetics and Drug Resistance.
"Antibiotics are uniquely societal drugs because individual use affects others in the community and environment. Better stewardship, incentives, and establishment of a special regulatory category will improve how they are used, marketed, and developed through incentives to industry."
Stuart B. Levy, M.D.
President of APUA, professor at Tufts University School of Medicine
From the IOM 25th Anniversary Symposium (1996) and The Antibiotic Paradox (2002)
In case you missed it, our latest webinar
is now available for streaming.